Document Type : Original Article
Authors
1 Department of Clinical Pharmacy, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran
2 Neuroscience Research Center, Institute of Neuropharmacology, Department of Biochemistry, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
3 Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
4 Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences, Kerman, Iran
Abstract
Background: Hempseed oil is a suitable source of alpha-linolenic acid, an omega-3 polyunsaturated fatty acid. In this study, we aimed to evaluate the effects of hempseed oil on the plasma levels of inflammation markers interleukin-6 and tumor necrosis factor-α in maintenance hemodialysis patients.
Methods: This 8-week single-blind randomized study was conducted on 97 hemodialysis patients. Patients were randomly assigned to the hempseed oil (receiving 20 ml of hempseed oil per day) or control (receiving no intervention) group. The plasma concentrations of interleukin-6 and tumor necrosis factor-α were measured at baseline and at the end of the study.
Results: The plasma concentrations of interleukin-6 and tumor necrosis factor- α changed significantly in neither of the group. Furthermore, the comparison of changes in the concentrations of IL-6 and TNF-α throughout the study showed no significant difference between the hempseed oil and control groups.
Conclusion: Hempseed oil consumption did not decrease inflammation in the maintenance hemodialysis patients.
Keywords
- Akchurin M, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif 2015; 39(1-3):84-92.
- Khor BH, Narayanan SS, Sahathevan S, Gafor AH, Daud ZA, Khosla P, et al. Efficacy of nutritional interventions on inflammatory markers in haemodialysis patients: a systematic review and limited meta-analysis. Nutrients 2018; 10(4):397.
- Callaway JC. Hempseed as a nutritional resource: an overview. Euphytica 2004; 140:65-72.
- Simopoulos AP. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 2006; 60(9):502-7.
- Noori N, Dukkipati R, Kovesdy CP, Sim JJ, Feroze U, Murali SB, et al. Dietary omega-3 fatty acid, ratio of omega-6 to omega-3 intake, inflammation, and survival in long-term hemodialysis patients. Am J Kidney Dis 2011; 58(2):248-56.
- Rodriguez-Leyva D, Pierce GN. The cardiac and haemostatic effects of dietary hempseed. Nutr Metab (Lond) 2010; 7:32.
- Türk S, Akbulut M, Yildiz A, Gürbilek M, Gönen S, Tombul Z, et al. Comparative effect of oral pulse and intravenous calcitriol treatment in hemodialysis patients: the effect on serum IL-1 and IL-6 levels and bone mineral density. Nephron 2002; 90(2):188-94.
- Pupim LB, Himmelfarb J, McMonagle E, Shyr Y, Ikizler TA. Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stress. Kidney Int 2004; 65(6):2371-9.
- Bowden RG, Wilson RL, Deike E, Gentile M. Fish oil supplementation lowers C‐reactive protein levels independent of triglyceride reduction in patients with end‐stage renal disease. Nutr Clin Pract 2009; 24(4):508-12.
- Kaul N, Kreml R, Austria JA, Richard MN, Edel AL, Dibrov E, et al. A comparison of fish oil, flaxseed oil and hempseed oil supplementation on selected parameters of cardiovascular health in healthy volunteers. J Am Coll Nutr 2008; 27(1):51-8.
- Mirfatahi M, Tabibi H, Nasrollahi A, Hedayati M, Taghizadeh M. Effect of flaxseed oil on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients: a randomized controlled trial. Int Urol Nephrol 2016; 48(8):1335-41.
- Lemos JR, de Alencastro MG, Konrath AV, Cargnin M, Manfro RC. Flaxseed oil supplementation decreases C-reactive protein levels in chronic hemodialysis patients. Nutr Res 2012; 32(12):921-7.
- Khalatbari Soltani S, Jamaluddin R, Tabibi H, Mohd Yusof BN, Atabak S, Loh SP, et al. Effects of flaxseed consumption on systemic inflammation and serum lipid profile in hemodialysis patients with lipid abnormalities. Hemodial Int 2013; 17(2):275-81.
- Leizer C, Ribnicky D, Poulev A, Dushenkov S, Raskin I. The composition of hemp seed oil and its potential as an important source of nutrition. Journal of Nutraceuticals, Functional & Medical Foods 2000; 2(4):35-53.
- Callaway J, Laakkonen TT. Cultivation of Cannabis oil seed varieties in Finland. [cited 2020 Oct 12] Available from: https://www.druglibrary.org/olsen/hemp/iha/iha03114.html.
- Oomah BD, Busson M, Godfrey DV, Drover JC. Characteristics of hemp (Cannabis sativa L.) seed oil. Food Chem 2002; 76(1):33-43.
- Bouic P, Etsebeth S, Liebenberg RW, Albrecht CF, Pegel K, Van Jaarsveld PP. Beta-sitosterol and beta-sitosterol glucoside stimulate human peripheral blood lymphocyte proliferation: Implications for their use as an immunomodulatory vitamin combination. Int J Immunopharmacol 1996; 18(12):693-700.
- Paniagua-Pérez R, Flores-Mondragón G, Reyes-Legorreta C, Herrera-López B, Cervantes-Hernández I, Madrigal-Santillán O, et al. Evaluation of the anti-inflammatory capacity of beta-sitosterol in rodent assays. Afr J Tradit Complement and Altern Med 2017; 14(1):123-30.
- Prieto JM, Recio MC, Giner RM. Anti-inflammatory activity of β-sitosterol in a model of oxazoloneinduced contact-delayed-type hypersensitivity. Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas 2006; 5(3):57-62.
- Fraile L, Crisci E, Córdoba L, Navarro MA, Osada J, Montoya M. Immunomodulatory properties of beta-sitosterol in pig immune responses. Int Immunopharmacol 2012; 13(3):316-21.
- Bouic P, Clark A, Lamprecht J, Freestone M, Pool EJ, Liebenberg RW, et al. The effects of B-sitosterol (BSS) and B-sitosterol glucoside (BSSG) mixture on selected immune parameters of marathon runners: inhibition of post marathon immune suppression and inflammation. Int J Sports Med 1999; 20(04):258-62.
- Dahham SS, Tabana YM, Ahamed MB, Abdul Majid AM. In vivo anti-inflammatory activity of β-caryophyllene, evaluated by molecular imaging. Mol Med Chem 2015; 1:e1001.
- Bakır B, Him A, Özbek H, Düz E, Tütüncü M. Investigation of the anti-inflammatory and analgesic activities of β-caryophyllene. Int J Essen Oil Ther 2008; 2:41-4.
- de Cássia da Silveira e Sá R, Andrade LN, de Sousa DP. A review on anti-inflammatory activity of monoterpenes. Molecules 2013; 18(1):1227-54.
- Smith KS, Lee CL, Ridlington JW, Leonard SW, Devaraj S, Traber MG. Vitamin E supplementation increases circulating vitamin E metabolites tenfold in end‐stage renal disease patients. Lipids 2003; 38(8):813-9.
- Himmelfarb J, Phinney S, Ikizler TA, Kane J, McMonagle E, Miller G. Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients. J Ren Nutr 2007; 17(5):296-304.
- Khalili M, Naeimabadi A, Atashbar J, Ballar N, Raji-amirhasani A, Kamali D. Curcumin modulates the level of IL-17 and IL-10 cytokines in two models of experimental liver injury in male rats. JKMU 2018; 25(2):104-117.
- Mehrabani M, Raeiszadeh M, Najafipour H, Esmaeli Tarzi M, Amirkhosravi A, Poustforoosh A. Evaluation of the Cytotoxicity, Antibacterial, Antioxidant, and Anti-inflammatory Effects of Different Extracts of Punica granatum var. pleniflora. JKMU 2020; 27(5):414-425.
)